The Journal of Organic Chemistry
Article
128.7, 128.2, 127.9, 123.4, 80.5, 79.6, 76.4, 72.4, 71.3, 21.8; HRMS-ESI
(m/z): calcd. for C20H17NaNO4 [M + Na]+: 358.1055, found 358.1066.
2-((2-Methoxypent-4-en-1-yl)oxy)isoindoline-1,3-dione (53c).
Colorless oil (13% over 3 steps). IR (neat): 2930, 1786, 1730, 1473,
128.1, 127.3, 107.6, 83.9, 78.8, 64.4, 34.5; HRMS-ESI (m/z): calcd. for
C12H15O2 [M + H]+: 191.1072, found 191.1074.
tert-Butyl((4-methyltetrahydrofuran-2-ol)methoxydiphenylsilane
(55c). N-Alkoxyphthalimide 53c (88 mg, 0.33 mmol) was subjected to
general cyclization procedure A. To the crude mixture were sequentially
added imidazole (45 mg, 0.66 mmol) and then tert-butyldiphenylsilyl
chloride (137 mg, 0.50 mmol), and the mixture was stirred overnight.
The solvent was evaporated, and the residue was dissolved in Et2O (50
mL). The organic layers were washed with brine (20 mL) and dried over
Na2SO4, and concentrated using rotary evaporation. The crude product
was purified using flash column chromatography (4:1 hexanes/EtOAc)
to afford 55c as a colorless oil (28 mg, 20%, two steps, cis:trans > 95:5).
1
1382, 1186, 1134, 1082, 986, 873, 717 cm−1; H NMR (400 MHz,
C6D6): δ = 7.29 (dd, J = 3.0, 5.2 Hz, 2 H), 6.80 (dd, J = 3.0, 5.5 Hz, 2 H),
5.78 (tdd, J = 7.0, 10.1, 17.2 Hz, 1 H), 5.06 (dd, J = 1.7, 17.5 Hz, 1 H),
5.00 (dd, J = 0.9, 10.1 Hz, 1 H), 4.22−4.14 (m, 1 H), 4.12−4.03 (m, 1
H), 3.59−3.48 (m, 1 H), 3.26 (s, 3 H), 2.30−2.22 (m, 2 H)); 13C NMR
(100 MHz, CDCl3): δ = 163.3, 134.4, 133.4, 128.9, 123.5, 118.0, 79.3,
78.2, 57.5, 35.2; HRMS-ESI (m/z): calcd. for C15H15NaN2O [M +
Na]+: 262.1082, found 262.1087.
1
IR (neat): 2969, 2921, 2856, 1739, 1478, 1434, 1117, 708 cm−1; H
2-((2-Methoxypent-4-yn-1-yl)oxy)isoindoline-1,3-dione (53d).
Colorless oil (60%). IR (neat): 2982, 2926, 1791, 1734, 1473, 1382,
NMR (300 MHz, C6D6): δ = 7.91−7.80 (m, 4 H), 7.27−7.20 (m, 6 H),
4.11−4.00 (m, 1 H), 3.86−3.66 (m, 3 H), 3.29 (t, J = 8.2 Hz, 1 H), 2.07−
1.90 (m, 1 H), 1.82−1.70 (m, 1 H), 1.27−1.13 (m, 10 H), 0.79 (d, J = 6.6
Hz, 3 H); 13C NMR (100 MHz, C6D6/CDCl3 ∼2/1): δ = 136.4, 134.4,
130.2, 128.3, 80.8, 77.7, 75.5, 67.3, 37.2, 35.0, 27.5, 19.9, 17.5; HRMS-
ESI (m/z): calcd. for C22H30NaSiO2 [M + Na]+: 377.1913, found
377.1911.
tert-Butyl((4-methylenetetrahydrofuran-2-yl)methoxy)diphenyl-
silane (55d). N-Alkoxyphthalimide 53d (160 mg, 0.61 mmol) was
subjected to general cyclization procedure A. To the crude mixture were
sequentially added imidazole (81 mg, 1.2 mmol), and then tert-
butyldiphenylsilyl chloride (202 mg, 0.74 mmol), and the mixture was
stirred overnight. The solvent was evaporated, and the residue was
dissolved in Et2O (50 mL). The organic layer was washed with brine (20
mL) and dried over Na2SO4, and concentrated using rotary evaporation.
The crude product was purified using flash column chromatography
(25:1 hexanes/EtOAc) to afford 55d as a colorless oil (60 mg, 25%, two
steps). IR (neat): 2982, 2926, 1791, 1734, 1473, 1382, 1269, 1182, 1108,
1030, 991,882, 708 cm−1; 1H NMR (400 MHz, C6D6): δ = 7.84−7.77
(m, 4 H), 7.23 (t, J = 2.9 Hz, 6 H), 4.83 (quin, J = 2.2 Hz, 1 H), 4.70 (t, J
= 2.1 Hz, 1 H), 4.36−4.28 (m, 1 H), 4.21−4.14 (m, 1 H), 4.10−4.03 (m,
1 H), 3.71 (dd, J = 2.6, 4.7 Hz, 2 H), 2.37−2.31 (m, 2 H), 1.17 (s, 9 H);
13C NMR (100 MHz, CDCl3): δ = 147.9, 135.6, 133.6, 129.6, 127.6,
1
1269, 1182, 1108, 1030, 991, 882, 708 cm−1; H NMR (400 MHz,
C6D6): δ = 7.27 (dd, J = 3.0, 5.5 Hz, 2 H), 6.78 (dd, J = 3.0, 5.5 Hz, 2 H),
4.27 (d, J = 5.5 Hz, 2 H), 3.58 (quin, J = 5.5 Hz, 1 H), 3.15 (s, 3 H),
2.35−2.32 (m, 2 H), 1.68 (t, J = 2.7 Hz, 1 H); 13C NMR (100 MHz,
C6D6/CDCl3 ∼ 2/1): δ = 163.8, 134.8, 129.5, 123.9, 80.2, 79.3, 77.7,
71.2, 58.1, 21.2; HRMS-ESI (m/z): calcd. for C14H14NO4 [M + H]+:
260.0923, found 260.0925.
2-((2-(Ethoxy)pent-4-en-1-yl)oxy)isoindoline-1,3-dione (53e). Col-
orless oil (35% over 3 steps). IR (neat): 2978, 2891, 1795, 1734, 1473,
1373, 1256, 1195, 1108, 1026, 878, 791, 704 cm−1; 1H NMR (400 MHz,
CDCl3): δ = 7.88 (dd, J = 3.0, 5.2 Hz, 2 H), 7.79 (dd, J = 3.2, 5.3 Hz, 2
H), 5.90 (tdd, J = 7.0, 10.1, 17.2 Hz, 1 H), 5.19 (d, J = 17.1 Hz, 1 H), 5.14
(d, J = 10.1 Hz, 1 H), 4.32−4.20 (m, 2 H), 3.86−3.78 (m, 1 H), 3.75−
3.60 (m, 2 H), 2.49−2.36 (m, 2 H), 1.19 (t, J = 7.0 Hz, 3 H); 13C NMR
(100 MHz, C6D6): δ = 163.5, 134.7, 134.1, 129.8, 123.4, 118.0, 80.3,
77.4, 65.6, 36.6, 16.0; HRMS-ESI (m/z): calcd. for C15H18NO4 [M +
H]+: 276.1234, found 276.1236.
2-((2-Ethoxypent-4-yn-1-yl)oxy)isoindoline-1,3-dione (53f). Col-
orless oil (35%). IR (neat): 2982, 2926, 1791, 1734, 1473, 1382, 1269,
1182, 1108, 1030, 991, 882, 708 cm−1; 1H NMR (400 MHz, CDCl3):δ =
7.90−7.82 (m, 2 H), 7.81−7.70 (m, 2 H), 4.44−4.28 (m, 2 H), 3.94−
3.84 (m, 1 H), 3.75−3.58 (m, 2 H), 2.61 (dd, J = 2.7, 6.0 Hz, 2 H), 2.02
(t, J = 2.6 Hz, 1 H), 1.15 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz,
CDCl3): δ =163.3, 134.5, 128.9, 123.5, 79.9, 78.9, 75.7, 70.5, 65.5, 21.1,
15.3; HRMS-ESI (m/z): calcd. forC15H15NaNO4 [M + Na]+: 296.0899,
found 296.0897
Synthesis of 55a−g. (4-Methyl-5-phenyltetrahydrofuran-2-yl)-
methanol (55a). N-Alkoxyphthalimide 53a (62 mg, 0.18 mmol) was
subjected to general cyclization procedure A. Purification with the
general procedure and finally by flash column chromatography (4:1
hexanes/EtOAc) afforded 55a as a colorless oil (42 mg, 74%, ratio
53:45:2). IR (neat): 3404, 2917, 2865, 1713, 1456, 1273, 1069, 1021,
704 cm−1; 1H NMR (400 MHz, CDCl3): δ = 7.31−7.15 (m, 5 H), 5.01
(d, J = 5.5 Hz, 0.02 H), 4.95 (d, J = 7.0 Hz, 0.44 H), 4.43−4.36 (m, 0.02
H), 4.36−4.29 (m, 0.09 H), 4.26 (d, J = 8.5 Hz, 0.5 H), 4.22−4.14 (m,
0.39 H), 4.12−4.03 (m, 0.4 H), 3.84−3.75 (m, 0.42 H), 3.73−3.63 (m, 1
H), 3.62−3.54 (m, 0.42 H), 3.51 (td, J = 6.0, 11.7 Hz, 0.14 H), 2.55 (spt,
J = 7.2 Hz, 0.45 H), 2.21−1.89 (m, 2.45 H), 1.77−1.66 (m, 0.51 H),
1.55−1.45 (m, 0.09 H), 1.45−1.33 (m, 0.47 H), 0.95 (d, J = 6.1 Hz, 1.6
H), 0.56 (d, J = 7.0 Hz, 0.12 H), 0.54−0.49 (m, 1.33 H); 13C NMR (100
MHz, CDCl3): δ = 140.7, 140.1, 128.4, 128.4, 127.9, 127.8, 127.1, 126.5,
126.4, 126.3, 88.7, 87.7, 83.9, 79.6, 79.1, 78.3, 65.8, 65.3, 65.2, 43.8, 42.0,
37.6, 36.8, 36.2, 35.4, 16.6, 16.2, 15.3; HRMS-ESI (m/z): calcd. for
C12H16NaO2 [M + Na]+: 215.1048, found 215.1046.
104.2, 79.8, 71.3, 66.0, 34.9, 26.8, 19.2; HRMS-ESI (m/z): calcd. for
C22H28NaSiO2 [M + Na]+:375.1756, found 375.1753.
tert-Butyl((4,5-dimethyltetrahydrofuran-2-yl)methoxy)diphenyl-
silane (55e). N-Alkoxyphthalimide 53e (250 mg, 0.91 mmol) was
subjected to general cyclization procedure C. To the crude mixture were
sequentially added imidazole (116 mg, 1.7 mmol) and then tert-
butyldiphenylsilyl chloride (370 mg, 1.36 mmol), and the mixture was
stirred overnight. The solvent was evaporated, and the residue was
dissolved in Et2O (50 mL). The organic layer was washed with brine (20
mL), dried over Na2SO4, and concentrated using rotary evaporation.
The crude product was purified using flash column chromatography
(30:1 hexanes/Et2O) to afford 55e (major isomer) as a colorless oil (200
mg, 62%, two steps, ratio 93:7 mixture of isomers). IR (neat): 2965,
2921, 2843, 1469, 1426, 1378, 1265, 1113, 830, 795, 739, 704 cm−1; 1H
NMR (400 MHz, C6D6): δ = 7.90−7.81 (m, 4 H), 7.26−7.21 (m, 6 H),
4.04−3.95 (m, 1 H), 3.92 (quin, J = 6.5 Hz, 1 H), 3.81−3.73 (m, 2 H),
2.01−1.89 (m, 1 H), 1.78 (td, J = 7.2, 12.3 Hz, 1 H), 1.28 (td, J = 8.0, 12.4
Hz, 1 H), 1.20 (s, 9 H), 1.03 (d, J = 6.4 Hz, 3 H), 0.73 (d, J = 7.0 Hz, 3
H); 13C NMR (100 MHz, CDCl3): δ = 135.7, 135.7, 133.8, 133.7, 129.5,
127.6, 78.8, 77.6, 67.0, 36.2, 35.9, 26.8, 19.2, 16.8, 14.9; HRMS-ESI (m/
z): calcd. for C23H32NaSiO2 [M + Na]+:391.2069, found 391.2064.
tert-Butyl((5-methyl-4-methylenetetrahydrofuran-2-yl)methoxy)-
diphenylsilane (55f). N-Alkoxyphthalimide 53f (100 mg, 0.36 mmol)
was subjected to general cyclization procedure A. To the crude mixture
were sequentially added imidazole (49 mg, 0.73 mmol) and then tert-
butyldiphenylsilyl chloride (120 mg, 0.44 mmol), and the mixture was
stirred overnight. The solvent was evaporated, and the residue was
dissolved in Et2O (30 mL). The organic layer was washed with brine (20
mL) and dried over Na2SO4, and concentrated using rotary evaporation.
The crude product was purified using flash column chromatography
(25:1 hexanes/EtOAc) to afford 55f as a colorless oil (60 mg, 25%, two
steps, cis:trans = 85:15). IR (neat): 2982, 2926, 1791, 1734, 1473, 1382,
(4-Methylene-5-phenyltetrahydrofuran-2-yl)methanol (55b). N-
Alkoxyphthalimide 53b (70 mg, 0.21 mmol) was subjected to general
cyclization procedure A. Solvent was evaporated and the mixture was
purified by flash column chromatography (4:1 hexanes/EtOAc) to
afford 55b as a colorless oil (28 mg, 70%, cis:trans > 95:5). IR (neat):
3391, 2921, 1717, 1447, 1260, 1095, 1026, 800,700 cm−1; 1H NMR (400
MHz, C6D6): δ = 7.33−7.27 (m, J = 6.8 Hz, 2 H), 7.21−7.00 (m, 3 H),
5.11 (s, 1 H), 4.82 (q, J = 2.2 Hz, 1 H), 4.60 (q, J = 2.0 Hz, 1 H), 3.92−
3.82 (m, 1 H), 3.59 (ddd, J = 3.1, 6.4, 11.7 Hz, 1 H), 3.41 (td, J = 5.9, 11.4
Hz, 1 H), 2.45−2.33 (m, 1 H), 2.21 (dd, J = 6.4, 15.6 Hz, 1 H), 1.56 (t, J
= 6.5 Hz, 1 H); 13C NMR (100 MHz, CDCl3): δ = 151.3, 141.0, 128.5,
1
1269, 1182, 1108, 1030, 991,882, 708 cm−1; H NMR (400 MHz,
C6D6):δ = 7.87−7.78 (m, 4 H), 7.25−7.20 (m, 6 H), 4.85−4.79 (m, 1
L
J. Org. Chem. XXXX, XXX, XXX−XXX